A sandwich ELISA for the estimation of human syndecan-2 and syndecan-4 in biological samples

Journal of Pharmaceutical and Biomedical Analysis

Volumn 34, Issue 4, 2004, Pages 797-801

  Seidel, Carina ^a   Gulyás, Miklós ^a   David, Guido ^b   Dobra, Katalin ^a   Theocharis, Achilleas D ^a   Hjerpe, Anders ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

ELISA; Mesothelioma; Proteoglycans; Syndecans

Indexed keywords

MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; RABBIT ANTISERUM; SYNDECAN 2; SYNDECAN 4;

ARTICLE; COMMERCIAL PHENOMENA; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; QUANTITATIVE ANALYSIS; SAMPLING; STANDARDIZATION;

EID: 1342264183     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0731-7085(03)00569-7     Document Type: Article

References (7)

1. Salmivirta M., Jalkanen M. Syndecan family of cell surface proteoglycans: developmentally regulated receptors for extracellular effector molecules. Experientia. 51:1995;863-872.
2. David G., Bai X.M., Van der Schueren B., Marynen P., Cassiman J.J., Van den Berghe H. Spatial and temporal changes in the expression of fibroglycan (syndecan-2) during mouse embryonic development. Development. 119:1993;841-854.
3. Saoncella S., Echtermeyer F., Denhez F., Nowlen J.K., Mosher D.F., Robinson S.D., Hynes R.O., Goetinck P.F. Syndecan-4 signals cooperatively with integrins in a Rho-dependent manner in the assembly of focal adhesions and actin stress fibers. Proc. Natl. Acad. Sci. U.S.A. 96:1999;2805-2810.
4. Dobra K., Andäng M., Syrokou A., Karamanos N.K., Hjerpe A. Differentiation of mesothelioma cells is influenced by the expression of proteoglycans. Exp. Cell Res. 258:2000;12-22.
5. Gulyas M., Hjerpe A. Proteoglycans and WT1 as markers for distinguishing adenocarcinoma, epithelioid mesothelioma, and benign mesothelium. J. Pathol. 199:2003;479-487.
6. Siedel C., Sundan A., Hjorth M., Turesson I., Dahl I.M.S., Abildgaard N., Waage A., Børset M. Serum syndecan-1: a new independent prognostic marker in multiple myeloma. Blood. 95:2000;388-392.
7. David G., van der Schueren B., Marynen P., Cassiman J.J., van den Berghe H. Molecular cloning of amphiglycan, a novel integral membrane heparan sulfate proteoglycan expressed by epithelial and fibroblastic cells. J. Cell Biol. 118:1992;961-969.